Literature DB >> 12414773

Humoral immune response associated with lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins.

A R Pachner1, D Dail, L Li, L Gurey, S Feng, E Hodzic, S Barthold.   

Abstract

The immune response to Borrelia burgdorferi, the causative agent of Lyme disease, is complex. We studied the immunoglobulin M (IgM) and IgG antibody response to N40Br, a sensu stricto strain, in the rhesus macaque(nonhuman primate [NHP]) model of infection to identify the spirochetal protein targets of specific antibody. Antigens used in enzyme-linked immunosorbent assays were whole-cell sonicates of the spirochete and recombinant proteins of B. burgdorferi. Immunoblotting with a commercially available strip and subsequent quantitative densitometry of the bands were also used. Sera from four different groups of NHPs were used: immunocompetent, transiently immunosuppressed, extended immunosuppressed, and uninfected. In immunocompetent and transiently immunosuppressed NHPs, there was a strong IgM and IgG response. Major proteins for the early IgM response were P39 and P41 and recombinant BmpA and OspC. Major proteins for the later IgG response were P39, P41, P18, P60, P66, and recombinant BmpA and DbpA. There was no significant response in the NHPs to recombinant OspA or to Arp, a 37-kDa protein that elicits an antibody response during infection in mice. Most antibody responses, except for that to DbpA, were markedly diminished by prolonged dexamethasone treatment. This study supports the hypothesis that recombinant proteins may provide a useful adjunct to current diagnostic testing for Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414773      PMCID: PMC130097          DOI: 10.1128/cdli.9.6.1348-1355.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  37 in total

1.  Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity.

Authors:  E Fikrig; S W Barthold; W Sun; W Feng; S R Telford; R A Flavell
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

2.  Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice.

Authors:  S Feng; E Hodzic; B Stevenson; S W Barthold
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.

Authors:  M S Hanson; D R Cassatt; B P Guo; N K Patel; M P McCarthy; D W Dorward; M Höök
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Neurological Lyme disease: is there a true animal model?

Authors:  P K Coyle
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

Review 5.  Lyme neuroborreliosis in the rhesus monkey.

Authors:  J D England; R P Bohm; E D Roberts; M T Philipp
Journal:  Semin Neurol       Date:  1997-03       Impact factor: 3.420

6.  Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis.

Authors:  D Roessler; U Hauser; B Wilske
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice.

Authors:  L K Bockenstedt; E Hodzic; S Feng; K W Bourrel; A de Silva; R R Montgomery; E Fikrig; J D Radolf; S W Barthold
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

8.  Detection of active infection in nonhuman primates with Lyme neuroborreliosis: comparison of PCR, culture, and a bioassay.

Authors:  A R Pachner; W F Zhang; H Schaefer; S Schaefer; T O'Neill
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

9.  Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system.

Authors:  A R Pachner; E Delaney; T O'Neill
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

10.  Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi.

Authors:  J R Zhang; S J Norris
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more
  7 in total

1.  Expression of the bmpB gene of Borrelia burgdorferi is modulated by two distinct transcription termination events.

Authors:  Ramesh Ramamoorthy; Natalie A McClain; Aarti Gautam; Dorothy Scholl-Meeker
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

2.  Detection of established virulence genes and plasmids to differentiate Borrelia burgdorferi strains.

Authors:  Kamfai Chan; Sherwood Casjens; Nikhat Parveen
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

3.  Immunoglobulin-regulated expression of Borrelia burgdorferi outer surface protein A in vivo.

Authors:  Emir Hodzic; Stefan Tunev; Sunlian Feng; Kim J Freet; Stephen W Barthold
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Dynamic longitudinal antibody responses during Borrelia burgdorferi infection and antibiotic treatment of rhesus macaques.

Authors:  Monica E Embers; Nicole R Hasenkampf; Mary B Jacobs; Mario T Philipp
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

Review 5.  The mammalian host response to borrelia infection.

Authors:  Diego Cadavid
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

6.  Variable exposure and immunological response to Lyme disease Borrelia among North Atlantic seabird species.

Authors:  V Staszewski; K D McCoy; T Boulinier
Journal:  Proc Biol Sci       Date:  2008-09-22       Impact factor: 5.349

Review 7.  The pathogenesis of lyme neuroborreliosis: from infection to inflammation.

Authors:  Tobias A Rupprecht; Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.